Reference
Mellema WW, et al. Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: a case report. Lung Cancer 87: 201-203, No. 2, Feb 2015. Available from: URL: http://doi.org/10.1016/j.lungcan.2014.11.014 - Netherlands
Rights and permissions
About this article
Cite this article
Sorafenib. Reactions Weekly 1592, 200 (2016). https://doi.org/10.1007/s40278-016-15628-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-15628-9